Peter Vangheluwe obtained his Master’s degrees in bioscience engineering and cellular biotechnology at KU Leuven, Belgium, in 2000. He completed his PhD and postdoctoral studies investigating calcium-ion transporters in various diseases. Between 2009 and 2012, he received part of his training at the Membrane Protein Research Group, University of Alberta, Canada and in the Centre of Excellence at University of Copenhagen, Denmark. He was appointed as assistant professor at KU Leuven in 2011, associate professor in 2016 and professor in 2020. Since 2012, he is head of the Laboratory of Cellular Transport Systems at KU Leuven and has established ATP13A2 as a polyamine transporter implicated in Parkinson's disease (PD). He currently investigates how a disturbed polyamine homeostasis contributes to PD and explores therapeutic strategies to correct polyamine imbalances.
Associated Grants
-
-
Identification and Characterization of Small Molecule Activators of ATP13A2 for Parkinson’s Disease Therapy
2020
-
IMPACT-PD - Implications of Polyamine and Glucosylceramide Transport in Parkinson’s Disease
2020
-